-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Cellebrite DI (NASDAQ:CLBT) Stock Price Up 1.2%
Cellebrite DI (NASDAQ:CLBT) Stock Price Up 1.2%
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) rose 1.2% during trading on Friday . The stock traded as high as $4.18 and last traded at $4.18. Approximately 9,282 shares were traded during trading, a decline of 94% from the average daily volume of 152,588 shares. The stock had previously closed at $4.13.
Wall Street Analyst Weigh In
CLBT has been the subject of several analyst reports. Needham & Company LLC upped their target price on Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a report on Thursday, August 11th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. William Blair downgraded Cellebrite DI from an "outperform" rating to a "market perform" rating in a research note on Friday, August 12th. Finally, Bank of America downgraded Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $6.00 in a research note on Friday, August 12th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $9.71.
Get Cellebrite DI alerts:Cellebrite DI Price Performance
The stock has a market cap of $810.72 million, a price-to-earnings ratio of 5.81, a P/E/G ratio of 9.78 and a beta of 0.87. The business has a fifty day moving average of $5.00 and a 200 day moving average of $5.33.
Institutional Trading of Cellebrite DI
Several large investors have recently added to or reduced their stakes in CLBT. Phoenix Holdings Ltd. grew its position in Cellebrite DI by 303.6% in the first quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock worth $14,706,000 after acquiring an additional 1,727,379 shares in the last quarter. Greenhaven Road Investment Management L.P. bought a new stake in Cellebrite DI in the fourth quarter worth approximately $9,453,000. Blair William & Co. IL grew its position in Cellebrite DI by 3,021.1% in the first quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock worth $3,353,000 after acquiring an additional 507,190 shares in the last quarter. ARK Investment Management LLC bought a new stake in Cellebrite DI in the first quarter worth approximately $2,621,000. Finally, CIBC Asset Management Inc grew its position in Cellebrite DI by 5.8% in the first quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock worth $15,057,000 after acquiring an additional 129,244 shares in the last quarter. 20.41% of the stock is owned by institutional investors.About Cellebrite DI
(Get Rating)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Read More
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) rose 1.2% during trading on Friday . The stock traded as high as $4.18 and last traded at $4.18. Approximately 9,282 shares were traded during trading, a decline of 94% from the average daily volume of 152,588 shares. The stock had previously closed at $4.13.
凯乐布莱特DI有限公司(纳斯达克代码：CLBT-GET评级)在周五的交易中上涨1.2%。该股一度涨至4.18美元，最后报4.18美元。当日成交量约为9,282股，较152,588股的日均成交量下降94%。该股此前收盘价为4.13美元。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
CLBT has been the subject of several analyst reports. Needham & Company LLC upped their target price on Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a report on Thursday, August 11th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. William Blair downgraded Cellebrite DI from an "outperform" rating to a "market perform" rating in a research note on Friday, August 12th. Finally, Bank of America downgraded Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $6.00 in a research note on Friday, August 12th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $9.71.
CLBT一直是几份分析师报告的主题。Needham&Company LLC在8月11日周四的一份报告中将Cellebrite DI的目标价从6.00美元上调至6.50美元，并给予该公司“买入”评级。考恩将Cellebrite DI的目标价从13.00美元下调至10.00美元，并在8月12日(星期五)的一份研究报告中为该公司设定了“跑赢大盘”的评级。考恩将Cellebrite DI的目标价从13.00美元下调至10.00美元，并在8月12日(星期五)的一份研究报告中为该公司设定了“跑赢大盘”的评级。在8月12日星期五的一份研究报告中，威廉·布莱尔将Cellebrite DI的评级从“跑赢大盘”下调至“市场表现”。最后，在8月12日星期五的一份研究报告中，美国银行将Cellebrite DI的评级从买入下调至中性，并将该股的目标价从6.50美元下调至6.00美元。两名分析师对该股的评级为持有，六名分析师对该股的评级为买入。根据MarketBeat的数据，该公司目前的普遍评级为“适度买入”，平均目标价为9.71美元。
Cellebrite DI Price Performance
Cellebrite DI性价比
The stock has a market cap of $810.72 million, a price-to-earnings ratio of 5.81, a P/E/G ratio of 9.78 and a beta of 0.87. The business has a fifty day moving average of $5.00 and a 200 day moving average of $5.33.
该股市值为8.1072亿美元，市盈率为5.81倍，市盈率为9.78倍，贝塔系数为0.87。该业务的50日移动均线切入位在5.00美元，200日移动均线切入位在5.33美元。
Institutional Trading of Cellebrite DI
凯勒布利特DI的机构交易
About Cellebrite DI
关于Cellebrite DI
(Get Rating)
(获取评级)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.为法律批准的调查开发解决方案。其DI平台允许用户在整个调查生命周期中收集、审查、分析和管理与法律批准的调查有关的数字数据，并在各种案件中使用解决方案，包括剥削儿童、凶杀、反恐、边境控制、性犯罪、人口贩运、企业安全、知识产权盗窃和民事诉讼。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 免费获取StockNews.com关于Cellebrite DI(CLBT)的研究报告
- 华尔街对Datadog的热情会带来巨大的收益吗？
- MarketBeat：回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性？
- 需要关注的2只半导体类股走势逆转
- 小盘股的裁员是楼市的晴雨表吗？
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凯尔布赖特DI日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cellebrite DI和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧